BlackRock Fund Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$51.7M Buy
2,312,674
+376,993
+19% +$7.37M 0.01% 1667
2016
Q3
$35.9M Buy
1,935,681
+1,234,540
+176% +$23.3M 0.01% 1790
2016
Q2
$11.4M Sell
701,141
-2,585
-0.4% -$38K ﹤0.01% 2328
2016
Q1
$8.22M Sell
703,726
-30,801
-4% -$344K ﹤0.01% 2468
2015
Q4
$8.58M Buy
734,527
+19,812
+3% +$251K ﹤0.01% 2530
2015
Q3
$8.75M Sell
714,715
-4,416
-0.6% -$56.3K ﹤0.01% 2457
2015
Q2
$6.78M Sell
719,131
-18,264
-2% -$169K ﹤0.01% 2734
2015
Q1
$6.53M Buy
737,395
+8,440
+1% +$85.3K ﹤0.01% 2689
2014
Q4
$7.31M Buy
728,955
+99,582
+16% +$854K ﹤0.01% 2657
2014
Q3
$4.22M Sell
629,373
-34,133
-5% -$239K ﹤0.01% 2850
2014
Q2
$4.76M Buy
663,506
+586,212
+758% +$4.67M ﹤0.01% 2870
2014
Q1
$780K Buy
77,294
+9,417
+14% +$86.7K ﹤0.01% 3209
2013
Q4
$539K Buy
67,877
+2,908
+4% +$27.1K ﹤0.01% 3225
2013
Q3
$644K Sell
64,969
-3,366
-5% -$26.5K ﹤0.01% 3196
2013
Q2
$403K Buy
+68,335
New +$230K ﹤0.01% 3185

Other funds holding BEAT

BlackRock Fund Advisors's BEAT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its BioTelemetry, Inc. (BEAT) stake by 19% in Q4 2016, buying an estimated $7.37M and bringing the position to 2,312,674 shares worth $51.7M. The position accounts for 0.01% of the portfolio, ranked #1667.

BlackRock Fund Advisors first reported a position in BEAT in Q2 2013 and has held it in 15 quarters since. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • BlackRock Fund Advisors held 2,312,674 shares of BioTelemetry, Inc. worth $51.7M as of Q4 2016.
  • BlackRock Fund Advisors bought 376,993 BioTelemetry, Inc. shares in Q4 2016, an estimated $7.37M.
  • BioTelemetry, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1667 holding.
  • BlackRock Fund Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 15 quarters since.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.